Top

Published in:

01-08-2016 | Original Scientific Report

Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence

Authors: Masaaki Yamamoto, Yukinori Kurokawa, Yasuhiro Miyazaki, Tomoki Makino, Tsuyoshi Takahashi, Makoto Yamasaki, Kiyokazu Nakajima, Shuji Takiguchi, Masaki Mori, Yuichiro Doki

Published in: World Journal of Surgery | Issue 8/2016

Abstract

Background

Hypercoagulation is associated with tumor progression and metastasis in various types of malignancy. We compared the prognostic value of preoperative plasma fibrinogen level with those of other prognostic markers in patients with gastric cancer and assessed whether fibrinogen level was an independent prognostic indicator.

Methods

We collected preoperative data from 609 consecutive patients with gastric cancer who underwent curative gastrectomy. A receiver operating curve (ROC) was used to compare the sensitivity and specificity of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), C-reactive protein (CRP), platelet count, platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), and fibrinogen level in predicting recurrence. Recurrence-free survival (RFS) and overall survival (OS) were compared between the normal and high fibrinogen groups.

Results

In the ROC analysis, the area under the curve (AUC) was 0.534 for CEA, 0.552 for CA19-9, 0.587 for CRP, 0.565 for platelet count, 0.567 for PLR, 0.522 for NLR, and 0.692 for fibrinogen. Plasma fibrinogen level increased with tumor stage. The high fibrinogen (≥350 mg/dl) group had significantly worse RFS (p < 0.001) and OS (p < 0.001) than the normal fibrinogen (<350 mg/dl) group. Cox multivariate analysis of RFS revealed that fibrinogen level was an independent prognostic factor (p < 0.001) in addition to sex, pT stage, and pN stage.

Conclusions

Preoperative plasma fibrinogen level had the highest predictive value for recurrence among seven known prognostic markers. Since fibrinogen level is an independent factor for RFS, it would be useful for predicting prognosis after gastric cancer surgery.

Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386CrossRefPubMed

Shinohara S, Korenaga D, Edagawa A et al (2013) Significant prognostic factors in patients with Stage IV gastric cancer with special reference to the curability of surgery. Surg Today 43(1):40–47CrossRefPubMed

Yoshikawa T, Rino Y, Yukawa N et al (2014) Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy. Surg Today 44(1):11–21CrossRefPubMed

Kochi M, Fujii M, Kanamori N et al (2000) Evaluation of serum CEA and CA19-9 levels as prognostic factors in patients with gastric cancer. Gastric Cancer 3(4):177–186CrossRefPubMed

Huang ZB, Zhou X, Xu J et al (2014) Prognostic value of preoperative serum tumor markers in gastric cancer. World J Clin Oncol 5(2):170–176CrossRefPubMedPubMedCentral

Kim DK, Oh SY, Kwon HC et al (2009) Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer. BMC Cancer 9:155CrossRefPubMedPubMedCentral

Ikeda M, Furukawa H, Imamura H et al (2002) Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 9(3):287–291CrossRefPubMed

Zhou X, Du Y, Huang Z et al (2014) Prognostic value of PLR in various cancers: a meta-analysis. PLoS One 9(6):e101119CrossRefPubMedPubMedCentral

Shimada H, Takiguchi N, Kainuma O et al (2010) High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer 13(3):170–176CrossRefPubMed

10.

Trousseau A (1965) Phlegmasia alba dolens. In: Clinique Medicale de L’Hotel Dieu de Paris, 2nd edition. Balliere, p 654–656

11.

Di Micco P, Romano M, Niglio A et al (2001) Alteration of haemostasis in non-metastatic gastric cancer. Dig Liver Dis 33(7):546–550CrossRefPubMed

12.

Yamashita H, Kitayama J, Nagawa H (2005) Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancer. Jpn J Clin Oncol 35(10):595–600CrossRefPubMed

13.

Yamashita H, Kitayama J, Kanno N et al (2006) Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer. BMC Cancer 6:147CrossRefPubMedPubMedCentral

14.

Sano T, Aiko T (2011) New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer 14(2):97–100CrossRefPubMed

15.

Takeuchi H, Ikeuchi S, Kitagawa Y et al (2007) Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus. J Gastroenterol Hepatol 22(12):2222–2227CrossRefPubMed

16.

Dvorak HF (1987) Thrombosis and cancer. Hum Pathol 18(3):275–284CrossRefPubMed

17.

Modrau II, Iversen LL, Thoriacius-Ussing OO (2001) Hemostatic alterations in patients with benign and malignant colorectal disease during major abdominal surgery. Thromb Res 104(5):309–315CrossRefPubMed

18.

Bennett JS, Hoxie JA, Leitman SF et al (1983) Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody. Proc Natl Acad Sci USA 80(9):2417–2421CrossRefPubMedPubMedCentral

19.

Honn KV, Tang DG, Crissman JD (1992) Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev 11(3–4):325–351CrossRefPubMed

20.

Languino LR, Plescia J, Duperray A et al (1993) Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-I -dependent pathway. Cell 73(7):1423–1434CrossRefPubMed

21.

Biggerstaff JP, Seth N, Amirkhosravi A et al (1999) Soluble fibrin augments platelet/tumor cell adherence in vitro and in vivo, and enhances experimental metastasis. Clin Exp Metastasis 17(8):723–730CrossRefPubMed

22.

Lee SE, Lee JH, Ryu KW et al (2012) Preoperative plasma fibrinogen level is a useful predictor of adjacent organ involvement in patients with advanced gastric cancer. J Gastric Cancer 12(2):81–87CrossRefPubMedPubMedCentral

23.

Nagy JA, Meyers MS, Msse EM et al (1995) Pathogenesis of ascites tumor growth: fibrinogen influx and fibrin accumulation in tissues lining the peritoneal cavity. Cancer Res 55(2):369–375PubMed

24.

Ma Y, Qian Y, Lv W (2007) The correlation between plasma fibrinogen levels and the clinical features of patients with ovarian carcinoma. J Int Med Res 35(5):678–684CrossRefPubMed

Title: Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence
Authors: Masaaki Yamamoto
Yukinori Kurokawa
Yasuhiro Miyazaki
Tomoki Makino
Tsuyoshi Takahashi
Makoto Yamasaki
Kiyokazu Nakajima
Shuji Takiguchi
Masaki Mori
Yuichiro Doki
Publication date: 01-08-2016
Publisher: Springer International Publishing
Published in: World Journal of Surgery / Issue 8/2016
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-016-3474-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2016

Impact of Preoperative Exclusive Enteral Nutrition on Postoperative Complications and Recurrence After Bowel Resection in Patients with Active Crohn’s Disease

Do 3D Printing Models Improve Anatomical Teaching About Hepatic Segments to Medical Students? A Randomized Controlled Study

Challenges and Opportunities in the Provision of Surgical Care in Vanuatu: A Mixed Methods Analysis

Preoperative Nutritional Assessment by Controlling Nutritional Status (CONUT) is Useful to estimate Postoperative Morbidity After Esophagectomy for Esophageal Cancer

Adjuvant I-131 Lipiodol After Resection or Radiofrequency Ablation for Hepatocellular Carcinoma

Amputation Versus Limb-Salvage Surgery in Patients with Osteosarcoma: A Meta-analysis